Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9873 - 9880 of 11616 results
Employee Benefits: Important Wellness Plan and Mental Health/Substance Use Disorder Parity Effective Dates Have Arrived!
July 10, 2014| Blog| Viewpoint
Patent Hold-Up or Patent Hold-Out? Judge Essex Adds His Voice to the SEP-FRAND Debate
July 10, 2014| Alert| Viewpoint
And Speaking of Foreign Trademark Filing Strategy: Tesla Motors is Sued in China for Trademark Infringement
July 9, 2014| Blog| Viewpoint
ML Strategies FY2015 Massachusetts Budget Update: Conference Committee Budget
July 9, 2014| Advisory| Viewpoint
NY Wage Law Repeal a Mixed Blessing for Companies
July 9, 2014| Blog| Viewpoint
Backlash Over Facebook Timeline Experiment Serves as a Reminder: User Expectations Still Trump Fine Print
July 9, 2014| Blog| Viewpoint
Two Observations From the SEC's First Settlement Under its Municipalities Continuing Disclosure Cooperation Initiative
July 9, 2014| Blog| Viewpoint
CMS Proposes Changes to Sunshine Act Reporting
July 9, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.